Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Diabetes and Genomics: A New Perspective from Eric Topol, MD by tony sheng and kelly close For this issue, diaTribe had the chance to sit down with Eric Topol, MD, of The Scripps Research Institute and Scripps Health in San Diego and ask him about genomics (the study of genes and their functions) and its fascinating implications in diabetes and the future of diabetes therapy
doi: 10.1016/S2213-8587(19)30249-9 Erratum in: Lancet Diabetes Endocrinol
Conclusion We report that individuals with type 1 diabetes treated with SGLT2i therapy demonstrate preservation of renal function, reduced rates of hospitalisation and reduced risk of heart failure when compared with patients receiving GLP-1 RA
Q: Is a prescription required for obtaining this medication
Crit Rev Biochem Mol Biol 30 : 445600
